Glycemia and insulin need following FK 506 rescue therapy in liver transplant recipients.
作者信息
Mieles L, Gordon R D, Mintz D, Toussaint R M, Imventarza O, Starzl T E
机构信息
Department of Surgery, University of Pittsburgh, Pennsylvania 15261.
出版信息
Transplant Proc. 1991 Feb;23(1 Pt 2):949-53.
Abstract
摘要
相似文献
1
Glycemia and insulin need following FK 506 rescue therapy in liver transplant recipients.肝移植受者接受FK 506挽救治疗后的血糖水平和胰岛素需求情况。
Transplant Proc. 1991 Feb;23(1 Pt 2):949-53.
2
Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.他克莫司在胰腺移植中的应用：一项多中心分析。他克莫司胰腺移植研究组。
Clin Transplant. 1997 Aug;11(4):299-312.
3
Current status of FK 506 in liver transplantation.FK506在肝移植中的现状。
Transplant Proc. 1991 Jun;23(3):1902-5.
4
Use of FK 506 in pancreas transplantation.FK506在胰腺移植中的应用。
Transpl Int. 1996;9 Suppl 1:S251-7. doi: 10.1007/978-3-662-00818-8_65.
5
Complete reversal of FK 506 induced diabetes in a liver transplant recipient by change of immunosuppression to cyclosporine A.
Z Gastroenterol. 1996 Feb;34(2):128-31.
6
Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506.FK506 作用下原位肝移植术后排斥反应的发生率及治疗情况
Transplant Proc. 1991 Feb;23(1 Pt 2):928-30.
7
Characterization of the immunosuppressive activity of FK 506 in rat islet allografts.FK506在大鼠胰岛同种异体移植中的免疫抑制活性表征。
Transplant Proc. 1990 Apr;22(2):875.
8
FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.FK506治疗难治性肾移植排斥反应：来自肝移植的经验教训。
Clin Transplant. 1996 Aug;10(4):323-32.
9
Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls.肝移植受者从环孢素转换为基于FK 506的免疫抑制：益处与风险。
Transplant Proc. 1991 Feb;23(1 Pt 1):14-21.
10
FK 506--an investigational immunosuppressant.FK506——一种实验性免疫抑制剂。
Med Lett Drugs Ther. 1991 Oct 4;33(854):94.
引用本文的文献
1
Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes.移植后糖尿病：病因、治疗及对预后的影响
Endocr Rev. 2016 Feb;37(1):37-61. doi: 10.1210/er.2015-1084. Epub 2015 Dec 9.
2
Clinical islet cell transplantation. Are we there yet?临床胰岛细胞移植。我们成功了吗？
Int J Pancreatol. 1998 Dec;24(3):145-68. doi: 10.1007/BF02788418.
3
Post-transplant diabetes mellitus. The role of immunosuppression.移植后糖尿病。免疫抑制的作用。
Drug Saf. 1997 Apr;16(4):242-57. doi: 10.2165/00002018-199716040-00002.
4
The current status of hepatic transplantation at the University of Pittsburgh.匹兹堡大学肝脏移植的现状
Clin Transpl. 1995:145-70.
5
The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation.他克莫司与环孢素用于肝移植的匹兹堡随机试验。
J Am Coll Surg. 1996 Aug;183(2):117-25.
6
Long-term insulin requirement after liver transplantation with FK 506 in American veterans.美国退伍军人肝移植后使用FK 506的长期胰岛素需求情况。
Transplant Proc. 1993 Feb;25(1 Pt 1):677-8.
7
Adverse effects of FK 506 overdosage after liver transplantation.肝移植后FK 506过量的不良反应。
Transplant Proc. 1993 Feb;25(1 Pt 1):628-34.
8
Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.他克莫司。其药理学及在肝移植和肾移植中的治疗潜力综述。
Drugs. 1993 Oct;46(4):746-94. doi: 10.2165/00003495-199346040-00009.
9
FK 506-associated diabetes mellitus in the pediatric transplant population is a rare complication.儿童移植人群中与FK 506相关的糖尿病是一种罕见的并发症。
Transplant Proc. 1991 Dec;23(6):3171-2.
10
Effect of FK 506 on function of human islets of Langerhans.FK506对人胰岛功能的影响。
Transplant Proc. 1991 Dec;23(6):3164-5.
本文引用的文献
1
Steroid diabetes--a sign of overtreatment with steroids in the renal graft recipient?类固醇糖尿病——肾移植受者类固醇过度治疗的一个迹象？
Scand J Urol Nephrol Suppl. 1980;54:135-8.
2
HLA-A28 and steroid-induced diabetes in renal transplant patients.肾移植患者中的HLA - A28与类固醇诱导的糖尿病
JAMA. 1980 Feb 8;243(6):532-3.
3
Cyclosporine: action, pharmacokinetics, and effect in the BB rat model.环孢素：在BB大鼠模型中的作用、药代动力学及效果
Metabolism. 1983 Jul;32(7 Suppl 1):69-72. doi: 10.1016/s0026-0495(83)80014-6.
4
Morphological and functional changes of pancreatic B cells in cyclosporin A-treated rats.环孢素A处理大鼠胰腺B细胞的形态学和功能变化
Diabetologia. 1984 Sep;27(3):416-8. doi: 10.1007/BF00304861.
5
The refolding of urea-denatured ribonuclease A is catalyzed by peptidyl-prolyl cis-trans isomerase.肽基脯氨酰顺反异构酶催化尿素变性的核糖核酸酶A的重折叠。
Biochim Biophys Acta. 1985 Mar 22;828(1):39-42. doi: 10.1016/0167-4838(85)90006-8.
6
The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients.环孢素及联合免疫抑制对肾移植受者移植后糖尿病发生率的影响。
Transplantation. 1987 Sep;44(3):376-81. doi: 10.1097/00007890-198709000-00010.
7
Peripheral insulin resistance and decreased insulin secretion after cyclosporine A treatment.环孢素A治疗后外周胰岛素抵抗及胰岛素分泌减少。
Transplant Proc. 1988 Jun;20(3 Suppl 3):985-8.
8
Impaired glucose tolerance in cyclosporine-prednisolone-treated renal graft recipients.
Transplantation. 1988 Sep;46(3):370-2. doi: 10.1097/00007890-198809000-00007.
9
Effects of cyclosporin on insulin and C-peptide secretion in healthy beagles.
Diabetes. 1989 Jun;38(6):698-703. doi: 10.2337/diab.38.6.698.
10
Posttransplant hyperglycemia. Increased incidence in cyclosporine-treated renal allograft recipients.
Transplantation. 1989 Feb;47(2):278-81.
Zotero 插件